Browse
Submit Data
Databases
API
Help

Dataset Information

4 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

ABSTRACT: BOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially decrease the expression of GRP78 in tumour cells and ER stressed cells when compared to normal cells. BOLD-100 will be combined with cytotoxic FOLFOX chemotherapy in this study, with a dose escalation cohort to ensure tolerability and safety, followed by a cohort expansion phase.

DISEASE(S): Metastatic Colorectal Cancer,Pancreatic Cancer Metastatic,Gastric Cancers,Gastric Carcinoma,Colorectal Cancerpancreatic Cancergastric Cancerscholangiocarcinoma,Colorectal Cancer,Pancreatic Cancer,Cholangiocarcinoma Metastatic,Cholangiocarcinoma

PROVIDER: 2341799 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Interaction with ribosomal proteins accompanies ER stress-induction of the anticancer metallodrug BOLD-100/KP1339

Project description:The ruthenium-based anticancer agent BOLD-100/KP1339 has shown promising results in several in vitro and in vivo tumour models, as well as in early clinical trials. However, its mode of action remains to be fully elucidated. Recent evidence identified ER stress-induction and concomitant down-modulation of HSPA5 (GRP78) as key drug effects. By exploiting the naturally formed adduct between BOLD-100 and human serum albumin as an immobilization strategy, we were able to perform target profiling experiments that revealed the ribosomal proteins RPL10, RPL24 and the transcription factor GTF2I as potential interactors of this ruthenium(III) anticancer agent. Integrating these findings with proteomic profiling and transcriptomic experiments supported ribosomal disturbance and concomitant induction of endoplasmic reticulum (ER) stress. The formation of poly-ribosomes and ER swelling of treated cancer cells by electron microscopy validated this finding. Thus, the direct interaction of BOLD-100 with ribosomal proteins seems to accompany ER stress-induction and modulation of GRP78 in cancer cells.

2021-06-01 | PXD022449 | Pride

Bradyrhizobium elkanii strain:USDA 100 | isolate:USDA 100

Project description:Bradyrhizobium elkanii USDA 100 genome sequencing

| PRJNA834281 | ENA

Staphylococcus aureus strain:55-100-016 | isolate:55-100-016

Project description:Staphylococcus aureus strain:55-100-016 | isolate:55-100-016 Genome sequencing

| PRJNA738346 | ENA

Staphylococcus aureus strain:55-100-003 | isolate:55-100-003

Project description:Staphylococcus aureus strain:55-100-003 | isolate:55-100-003 Genome sequencing

| PRJNA738347 | ENA

Acidovorax sp. 100

Project description:Acidovorax sp. 100 Genome sequencing and assembly

| PRJNA442016 | ENA

Primary and adjacent non-malignant tissue samples of 100 HCC patients (mRNA)

Project description:Genome-wide mRNA expression profiles of 100 primary and matched non-malignant tissues of HCC patients from a Singapore patient cohort. HCC is a hetergenous disease and it is important to understand the underlying molecular mechanisms. Here, we studied the role of microRNAs in HCC by integrating microRNA and gene expression profiles of HCC patients.

2016-02-18 | GSE62043 | GEO

Primary and adjacent non-malignant tissue samples of 100 HCC patients (miRNA)

Project description:Genome-wide miRNA expression profiles of 100 primary and matched non-malignant tissues of HCC patients from a Singapore patient cohort. HCC is a hetergenous disease and it is important to understand the underlying molecular mechanisms. Here, we studied the role of microRNAs in HCC by integrating microRNA and gene expression profiles of HCC patients.

2016-02-18 | GSE62007 | GEO

Synechococcus sp. KORDI-100

Project description:Synechococcus sp. KORDI-100 Genome sequencing

| PRJNA207982 | ENA

µATACseq: ATACseq with as few as 100 cells

Project description:µATACseq: ATACseq with as few as 100 cells

| PRJNA631703 | ENA

Kentucky assay: Citrus accord, 100%

Project description:Kentucky assay: Citrus accord, 100%

| PRJNA610535 | ENA